Strength
250 mg/5mL
Manufacturer
Aurobindo Pharma LimitedNDC
65862010075
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Last Updated
8/20/2025
Active Ingredients
CEFPROZILApproval Type
Generic (ANDA)
FDA Application
ANDA065381On Market Since
1/30/2007
Related Drugs
Same classification
No related drugs found.